
Competition regulators from the EU have raided offices of AstraZeneca and Nycomed in connection with alleged attempts to block generic …
Nycomed has seen its sales inch downwards in the third quarter, as the decline of its biggest seller pantoprazole continued. …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

